Save the Date for our upcoming OTRADI & OBI 10th Anniversary Party on September 11, 2018
OBI Client Company Wins
- Aronora’s potential anti-clotting biological drug, Xisomab, has cleared FDA Phase I clinical trials.
- Aronora’s second biological drug, E-WE-Thrombin, has received Investigational New Drug (IND) approval with fast-track status from the FDA.
- Hemex Health was featured on NPR’s All Things Considered for their cutting-edge malaria detection device.
- Both Madorra and Hemex Health won $100,000 SBIR matching grants from Business Oregon.
AbSci, the first company to graduate from our Oregon Bioscience Incubator, has just raised an incredibly impressive $12M Series C investment!
Jennifer Fox, Executive Director of OTRADI/OBI, and Denise McCarty, Executive Director of the Oregon Bioscience Association, represented Oregon at Digital Health World Congress in London where they met Pilar Hermida, Head of Globilasation at i-Expand.com and Michelle Zimmerman, Director of Digital Marketing at Fitscript.com. #DigitalHealth
Accelerate Bio & Digital Health Happy Hour
Our monthly happy hour brings together creative and driven professionals who are passionate about promoting the growth of Portland’s Biotech and Digital Health sectors. Register now to attend our July 5th happy hour.
The OBI welcomed new client company, SUTUREGARD Medical, in May 2018.
SBIR Road Tour Oregon on July 17, 2018
The SBIR/STTR Road Tour – Oregon will be a 1-day live event on July 17, 2018 located at Portland State University. It will provide an exceptional opportunity for small businesses and those supporting them to meet directly with over 25 program managers from the 12 Federal agencies with SBIR/STTR Programs, as well as USPTO and SBA. Register now!